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Objective: The study objectives were to assess 1) postoperative satisfaction and the occurrence of compensatory
sweating after endoscopic thoracic sympathetic clipping in a consecutive series of patients and 2) the reversibility
of adverse effects by removing the surgical clips.
Methods: Between June 1998 and March 2006, 727 patients undergoing bilateral endoscopic thoracic sympa-
thetic clipping for hyperhidrosis or facial blushing were prospectively followed for postoperative satisfaction
and subjective compensatory sweating. The effect of removing the surgical clips was assessed in 34 patients
who underwent a subsequent reversal procedure after endoscopic thoracic sympathetic clipping. Satisfaction
and compensatory sweating were assessed using a visual analogue scale ranging from 0 to 10, with 10 indicating
the highest degree.
Results: Follow-up was complete in 666 patients (92%). The median age was 26.9 years, and 383 (53%) were men.
The level of sympathetic clipping was T2 in 399 patients (55%), T2þ3 in 55 patients (8%), and T3þ4 in 273 patients
(38%). Median follow-up was 10.4 months (range 0–83 months). Excellent satisfaction (8–10 on visual analogue
scale) was seen at last follow-up in 288 (74%) of the T2 group, 33 (62%) of the T2þ3 group, and 184 (85%) of
the T3þ4 group. Postoperative satisfaction was significantly higher in the T3þ4 group when compared with the T2
or T2þ3 groups (P< .01). Severe compensatory sweating (8–10 on the visual analogue scale) was reported in 42
(13%) of the T2 group, 11 (28%) of the T2þ3 group, and 17 (8%) of the T3þ4 group. Postoperative compensatory
sweating was significantly lower in the T3þ4 group when compared with the T2 or T2þ3 groups (P<.05). Thirty-four
patients have subsequently undergone removal of the surgical clips after endoscopic thoracic sympathetic clipping.
Follow-up was complete in 31 patients. The reasons for removal included severe compensatory sweating in 32 pa-
tients, anhydrosis of the upper limb in 4 patients, lack of improvement or recurrence of hyperhidrosis in 5 patients, and
other adverse symptoms in 5 patients. The reversal procedure was done after a median time of 11.0 months (range 1–
57 months) after endoscopic thoracic sympathetic clipping. The initial level of clipping was T2 in 21 patients, T2þ3 in
7 patients, and T3þ4 in 6 patients. There was a trend toward fewer subsequent reversal procedures in the T3þ4 group
when compared with the T2 or T2þ3 groups (P¼ .06). Fifteen patients (48%) reported a substantial decrease in their
compensatory sweating (5–10 on the visual analogue scale) after reversal. Thirteen patients (42%) reported that their
initial hyperhidrosis or facial blushing has remained well controlled (8–10 on the visual analogue scale) after reversal.
There was no significant relationship between the original level of clipping and the interval between endoscopic
thoracic sympathetic clipping and the subsequent reversal and reversibility of symptoms.
Conclusion:When compared with endoscopic thoracic sympathetic clipping at the T2 or T2þ3 levels, endoscopic
thoracic sympathetic clipping at the T3þ4 level was associated with a higher satisfaction rate, a lower rate of se-
vere compensatory sweating, and a trend toward fewer subsequent reversal procedures. Subjective reversibility of
adverse effects after endoscopic thoracic sympathetic clipping was seen in approximately half of the patients who
underwent endoscopic removal of surgical clips. Although yet to be supported by electrophysiologic studies, re-
versal of sympathetic clipping seems to provide acceptable results and should be considered in selected patients.
GENERALTHORACIC SURGERYIdiopathic or primary hyperhidrosis (HH) is a chronic condi-
tion in which excessive sweating is seen in a focal pattern,
usually affecting the palms, axillae, or soles. If symptoms
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and can significantly interfere with daily activities. Although
HH is thought to be underreported, its prevalence has been
reported as 2.8% in the United States1 and 4.9% in China.2
The cause of primary HH remains unknown.
When conservative measures in the treatment of HH fail,
surgical treatment may be considered. First reported in 1920,
sympathectomy has become an accepted method for treating
HH,3 currently performed almost exclusively using video-
assisted techniques. Although thoracoscopic interruption
of the sympathetic trunk is associated with a high success
rate and low morbidity when used in the treatment of HH,
compensatory sweating (CS) remains the most commonlyrgery c June 2009
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SAbbreviations and Acronyms
CS ¼ compensatory sweating
ETS ¼ endoscopic thoracic sympathetic clipping
HH ¼ hyperhidrosis
VAS ¼ visual analogue scale
reported side effect, with severe and debilitating symptoms
reported in approximately 2% to 30% of patients.4-12 Vari-
ous technical modifications have been attempted to achieve
the highest patient satisfaction through optimal control of
HH, while avoiding the occurrence of significant CS. One
such approach is the method of clamping the sympathetic
nerve with surgical clips (endoscopic thoracic sympathetic
clipping [ETS]), rather than cutting, coagulating, or partially
removing the nerve.13 This method has the theoretic advan-
tage of reversibility of adverse effects of sympathectomy by
simple removal of the surgical clips if postsympathectomy
side effects are severe. A few authors have reported mixed
results for reversal in case reports or small case series.5,12-14
Yet, in the limited number of reported cases, the factors af-
fecting reversibility remain largely unknown. The purpose
of this study was therefore to assess the long-term satisfac-
tion and significance of CS after ETS in a consecutive series
of patients; to evaluate the effect of removal of surgical clips
after ETS on satisfaction, CS, and HH; and to define factors
that might adversely or positively affect the outcome of the
reversal procedure.
MATERIALS AND METHODS
Between June 1998 and March 2006, all patients undergoing sympa-
thetic nerve block, sympathectomy, or sympathetic clipping for HH or facial
blushing at St Joseph’s Health Center in Toronto were included in a prospec-
tive follow-up study evaluating the results of their surgery. The degree of
postoperative HH or facial blushing, as well as satisfaction rate (defined
as relief of original symptoms and lack of side effects) and degree of CS af-
ter sympathetic surgery, were assessed at each follow-up event using a visual
analogue scale (VAS) ranging from 0 to 10, with 10 indicating the highest
degree of each index (Appendix 1). The first follow-up was 1 to 4 weeks
after surgery and then subsequently at 6- to 12-month intervals, through
clinic visits or telephone/e-mail interviews.
Only patients undergoing bilateral ETS under our current standardized
technique were included in the current analysis. All procedures were per-
formed under general anesthesia with single-lumen endotracheal intubation.
Patients were placed in a supine position with the arms abducted. Two 5-mm
ports were introduced in the midaxillary line at the third and fifth intercostal
spaces. We routinely used the Ternamian Endo TIP (Karl Storz, Tuttlingen,
Germany) cannula for initial access into the pleural space. The pleural space
was then insufflated with carbon dioxide to a pressure of less than 15 mm
Hg, and the second instrument port was introduced under direct vision.
The parietal pleura overlying the sympathetic nerve was incised below
the rib at the desired level of clipping (ie, below the second rib for T2 clip-
ping and below the third and fourth ribs for T3þ4 clipping), and the nerve
was double-clipped using the 5-mm Endoclip applier (autosuture endo-
scopic clips). After clip application, 5 mL of 0.25% bupivacaine solution
was injected along the site of pleural dissection for postoperative analgesia.
The lung was reinflated under direct vision, and all port sites were closedThe Journal of Thoracic and Cprimarily with absorbable stitches. Postoperative chest x-ray was performed
in the recovery unit, and the patient was discharged after 2 to 3 hours of
monitoring in the postoperative unit.
The most recent follow-up information available at the time of analysis
was used in the assessment of postoperative satisfaction and degree of CS
after ETS. For patients who subsequently underwent a redo or reversal pro-
cedure, data collected immediately before the subsequent procedure were
used in the analysis, as well as the most recent follow-up data after the
second procedure.
To obtain procedure-specific data, all patients who underwent reversal
(removal of surgical clip after ETS) were contacted via telephone or e-
mail and asked to complete a separate questionnaire in which they were
asked to grade their satisfaction, degree of CS, and degree of HH after
their reversal procedure (Appendix 2). The effect of the reversal procedure
was analyzed while comparing the anatomic level of ETS, the primary
indication for ETS, the time period since ETS, and the indication for
reversal.
Data were presented as mean  standard deviation. Difference in satis-
faction and degree of CS among groups was determined by the Kruskal–
Wallis test, and multiple comparison post-tests were performed by the
Tukey–Kramer method. Proportional difference among groups was deter-
mined using the chi-square test. All statistical analyses were performed
with SAS-based software (JMP version 5, SAS Institute, Cary, NC).
RESULTS
Patients
A total of 750 patients treated surgically for primary HH
or facial blushing were identified, 727 of whom were the
subject of this study. Twenty-three patients were excluded
from the analysis because of alternative surgical techniques,
including unilateral surgery, lumbar sympathectomy, open
thoracotomy, or a combination of methods.
There were 383 male patients (53%) and 344 female pa-
tients. The median age was 26.9 years (range, 14–65 years),
with 106 patients aged 10 to 20 years, 329 patients aged 21
to 30 years, 209 patients aged 31 to 40 years, and 83 patients
aged more than 41 years. Among the 727 eligible patients,
follow-up was complete in 666 (92%). Median follow-up
was 10.4 months (range, 0–83 months).
The primary indication for surgery was palmar HH in 538
patients, facial blushing or craniofacial sweating in 173 pa-
tients, and axillary HH in 16 patients (Figure 1). The ana-
tomic level of ETS was T2 (ETS-T2) in 399 patients,
T2þ3 (ETS-T2þ3) in 55 patients, and T3þ4 (ETS-T3þ4) in
273 patients (Figure 2). During the study period, our pre-
ferred surgical method has altered from the ETS-T2 level
for all indications, including facial blushing, craniofacial,
palmar, and axillary HH, to the ETS-T3þ4 level for primarily
palmar HH. This change was a result of growing evidence
showing that interruption of the sympathetic trunk at the
T2 level is unnecessary in the control of palmar HH and
might be associated with a higher rate of severe CS.15-19
In recent years we have discouraged patients from having
T2 clipping because of unsatisfactory results and higher in-
cidence of severe CS. During the study period, 57 patients
underwent more than 1 procedure. This included 25
(3.4%) redo ETS procedures and 34 (4.7%) reversals.ardiovascular Surgery c Volume 137, Number 6 1371
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Surgical complications were rare. Chest tube insertion and
drainage with subsequent hospital stay was necessary in 3 pa-
tients (0.4%) with pneumothorax and 1 patient because of
take-down of excessive adhesions. One patient required con-
version to a thoracotomy because of major bleeding as a result
of a superior vena cava tear. She recovered well after surgical
repair and experienced good control of her HH. Horner’s syn-
drome developed in 1 patient after ETS-T2þ3, and reversal
was requested after 3 months. One patient returned to the
emergency department with a mild fever on postoperative
day 2 but did not require treatment or hospital admission.
Postoperative results after ETS are shown in Table 1.
Among 666 patients with follow-up, 508 (76%) reported ex-
cellent satisfaction (8–10 on VAS). The mean satisfaction
score for all patients was 8.2  2. Excellent satisfaction
was seen in 288 (74%) of the T2 group, 33 (62%) of the
T2þ3 group, and 184 (85%) of the T3þ4 group. Postopera-
tive satisfaction was significantly higher in the T3þ4 group
when compared with the T2 or T2þ3 groups (P< .05).
The mean VAS score for the degree of persistent HH/facial
blushing after ETS was 1.9  1.8 for all patients. The mean
score was 2.2 1.9 for the T2 group, 1.6 1.7 for the T2þ3
group, and 1.5  1.3 for the T3þ4 groups, respectively. The
degree of persistent HH/facial blushing was significantly less
FIGURE 1. Surgical indication by year of surgery.
FIGURE 2. Level of sympathetic clipping by year of surgery.1372 The Journal of Thoracic and Cardiovascular Surin the T3þ4 group when compared with the T2 group (P<
.05), but not when compared with the T2þ3 group.
Severe CS (8–10 on VAS) was reported in 49 (15%) of
the T2 group, 13 (24%) of the T2þ3 group, and 17 (8%)
of the T3þ4 group. The mean CS score was 4.3  2.7 for
the T2 group, 5.3  2.9 for the T2þ3 group, and 3.7  2.5
for the T3þ4 group. Postoperative CS was significantly
lower in the T3þ4 group when compared with the T2 or
T2þ3 groups (P< .05). The proportion of patients reporting
severe CS was significantly lower in the T3þ4 group when
compared with the combined T2 and T2þ3 group (P< .01).
When the primary indication for surgery was evaluated,
452 patients (96%) treated for palmar HH, 138 patients
(89%) with facial blushing/sweating, and 15 patients
(94%) with axillary HH reported substantial relief from their
primary symptoms (0–5 on VAS) as a result of the ETS. Al-
though 85% of patients with primary symptoms of palmar
HH reported excellent satisfaction (8–10 on VAS), the rates
of excellent satisfaction in patients with primary symptoms
of facial blushing/sweating or axillary HH were only 62%
and 53%, respectively. However, the rates of moderate or
excellent postoperative satisfaction (4–10 on VAS) were
98%, 92%, and 87% for patients with palmar, facial, and
axillary HH, respectively (Figure 3). Thus, the majority of
patients experienced at least moderate improvement of their
symptoms after the surgical procedure.
Redo Endoscopic Thoracic Sympathetic Clipping
During the study period, 25 patients (3.4%) underwent
a redo ETS procedure. The level of initial ETS was T2 in 20
TABLE 1. Postoperative results and adverse outcomes (visual
analogue scale score)
Level of ETS T2 T2þ3 T3þ4
n 397 57 212
HH/FB 2.2  1.9y 1.6  1.7 1.5  1.3y P< .01*
CS 4.3  2.7y 5.3  2.9z 3.7  2.5y,z P< .01*
Satisfaction 8.0  2.4y 7.3  3.0z 8.8  1.8y,z P< .01*
ETS, Endoscopic thoracic sympathetic clipping; CS, compensatory sweating; HH, hy-
perhidrosis; FB, facial blushing. *P< .01 for comparison among all groups. yP< .05
for comparison between groups T2 and T3þ4. zP<.05 for comparison between groups
T2þ3 and T3þ4.
FIGURE 3. Postoperative satisfaction by surgical indication.gery c June 2009
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for redo ETS was suboptimal or unilateral control of symp-
toms in 20 patients and recurrent symptoms in 5 patients.
The median interval between ETS and redo ETS was 3.5
months for suboptimal results and 21.1 months for recurrence.
Sixteen of 18 patients underwent redo ETS after ETS-T2 be-
cause of suboptimal control of palmar HH. In 7 of these cases,
ETS-T3þ4 was performed at the time of redo surgery. In 1 case
after ETS-T3þ4, ETS-T2 was added to optimize control of fa-
cial HH and blushing. Seventeen patients (74% of those with
follow-up) reported excellent satisfaction after redo ETS.
Reversals
Thirty-four patients (4.7%) subsequently underwent a re-
versal procedure with surgical removal of the clips after
ETS. The procedure was done as a day procedure with a sim-
ilar setup as for the original surgery. The previously placed
incisions were used for port insertion. Mild adhesions were
frequently observed along the clips. However, there were no
or little adhesions between the lung and the chest wall. The
overlying pleura was reincised, and the clips were removed
by pulling the heel of the clip with a thin-nosed grasper. The
sympathetic chain was kept intact. All cases were completed
as planned, and there were no major complications or con-
versions to thoracotomy.
Among these patients, follow-up information after rever-
sal was complete in 31 (91%). Two patients were lost to fol-
low-up, and 1 patient refused to participate in the study. The
primary indication for reversal was severe CS in the majority
(n¼ 32) of patients. Other adverse symptoms seen in combi-
nation were anhydrosis of the upper limbs in 4 patients, lack
of improvement or recurrence of HH in 5 patients, and Horn-
er’s syndrome and sexual dysfunction in 1 patient each.
The reversal procedure was done after a median time of
11.0 months (range, 0.6–56.9 months) after ETS. Median
follow-up after the reversal procedure was 34.0 months
(range, 0–72.1 months). The original level of the ETS was
T2 in 21 patients (5.3% of total T2), T2þ3 in 8 patients
(14.5% of total T2þ3), and T3þ4 in 5 patients (1.8% of total
T3þ4). There was a trend toward fewer subsequent reversal
procedures in the T3þ4 group when compared with the T2
and T2þ3 groups (P¼ .05). Table 2 summarizes postreversal
results by the level of ETS. The mean time from ETS to re-
versal was 16.5 14.8 months in the T2 group, 21.1 21.7
months in the T2þ3 group, and 11.7  17.6 months in the
T3þ4 group. This was not significantly different among the
groups. The follow-up period after reversal was significantly
shorter in the T3þ4 group when compared with the T2 group
(5.1  6.1 months vs 34.0  20.3 months, P< .05).
Fifteen patients (48%) reported a substantial decrease in
their CS (5–10 on VAS) after reversal. Thirteen patients
(42%) reported that their initial HH or facial blushing has re-
mained well controlled (8–10 on VAS) after reversal. There
was no difference in the change in CS or the degree of HHThe Journal of Thoracic and Cafter reversal among the T2, T2þ3, and T3þ4 groups (P ¼
.09 and P¼ .72 for universal comparison among all groups).
Eight patients reported excellent satisfaction after reversal.
Postreversal satisfaction was significantly better in the T2
group when compared with the T2þ3 group (mean 5.4 
3.4 vs 1.3  1.9, P< .05). By using 6 months after ETS
as the cutoff time period to compare ‘‘early’’ versus
‘‘late’’ reversal, 12 patients (of 34) received their reversal
procedure within 6 months from their initial ETS procedure.
The proportion of patients reporting substantial decrease in
their CS after reversal was 67% in the early group and
37% in the late group (P¼ not significant). Postreversal sat-
isfaction was excellent in 36% of the early group and 22%
of the late group. Control of HH or facial blushing was well
maintained in 25% and 53% of the early and late groups, re-
spectively (P¼ not significant). Overall, there was no statis-
tical difference in the postoperative results or satisfaction
between the 2 groups (Table 3).
DISCUSSION
Primary or essential HH, defined as an excessive sweating
beyond that expected physiologically, affects a significant
proportion of the general population. Although benign in na-
ture, it might cause significant social, emotional, and profes-
sional disabilities. There is a potential role for genetic
predisposition, given a positive family history in up to
40% of the affected individuals.12 Social phobias are also
common, mainly in combination with facial blushing and
sweating,20,21 and add substantially to patients’ discomfort.
Nonsurgical treatment methods, including topical absorb-
ing powders, anticholinergic medications, botulinum toxin
injections, and various biofeedback methods, are usually
helpful only for patients with mild manifestations. Thus,
the majority of patients with severe forms of HH will ulti-
mately be offered a surgical sympathectomy as a definitive
treatment.
Originally used for various other indications (eg, epilepsy,
glaucoma, angina pectoris, reflex sympathetic dystrophy,
and Raynaud’s phenomenon), sympathectomy as a treatment
for HH was first reported in 1920.3
TABLE 2. Reversal cases and postreversal results by level of endoscopic
thoracic sympathetic clipping (visual analogue scale score)
Level of ETS T2 T2þ3 T3þ4
n 21 8 5
Time to reversal (mo) 16.5  14.8 21.1  21.7 11.7  17.6 NS
Follow-up time
after reversal (mo)
34.0  20.3y 30.4  27.0 5.1  6.1y P< .05*
Change in CS 4.5  3.4 1.4  3.0 3.2  2.9 NS
Control of HH 5.5  3.9 5.3  4.0 6.8  4.3 NS
Satisfaction 5.4  3.4z 1.3  1.9z 2.0  3.1 P< .05*
ETS, Endoscopic thoracic sympathetic clipping; CS, compensatory sweating; HH, hy-
perhidrosis; NS, not significant. *P< .05 for comparison among all groups. yP< .05
for comparison between groups T2 and T3þ4. zP<.05 for comparison between groups
T2 and T2þ3.ardiovascular Surgery c Volume 137, Number 6 1373
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widely used over the years. Those included the posterior,
supraclavicular, anterior transthoracic, and axillary transtho-
racic approaches.22 Although generally effective in control-
ling the HH, none of those techniques is simple, and the
morbidity related to the open approach is substantial.
Endoscopic sympathectomy, developed over the past de-
cade, has practically replaced the open techniques. Regard-
less of the method used to interrupt the sympathetic trunk,
the overall results are satisfactory, the complication rate is
small, and the morbidity is minimal.
There is little doubt that thoracoscopic sympathetic sur-
gery has provided a highly reliable solution for palmar
HH. This is reflected in numerous clinical reports of success-
ful control of symptoms by surgery in more than 95% of pa-
tients.4,8-10,12,14,16 Our results are in keeping with those
previous reports, with 96% of patients undergoing ETS
for palmar HH reporting substantial improvement (0–5 on
VAS) of their symptoms. This high success rate was associ-
ated with excellent satisfaction (8–10 on VAS) in 85% of
our patients undergoing ETS for palmar HH.
ETS was also highly successful in controlling the symp-
toms of facial blushing/sweating and axillary HH in our
patients with success rates of 89 and 94%, respectively.
However, we should emphasize that successful control of
symptoms was not necessarily associated with excellent sat-
isfaction. In our series, despite the high success rates, the rate
of excellent satisfaction was merely at the 50% to 60%
range for these 2 groups of patients. Therefore, for axillary
HH a local approach such as excision of sweat glands might
be better in controlling HH symptoms.
The optimal surgical technique and level of sympathetic
trunk interruption in thoracoscopic sympathetic surgery
are still under debate. Direct comparison between studies
is difficult because of the subjective characteristics and
lack of uniformity in reporting the measured outcomes.
Nevertheless, it is possible to draw some conclusions from
the existing literature regarding ETS. First, the results are
similar when comparing different techniques (clipping,
ablation, cauterization, and division) but for the same indi-
cation (location of HH) and at the same level of the sympa-
thetic trunk. Thus, one should expect good results when
operating on a patient with palmar HH, regardless of the
technique used.
TABLE 3. Reversal cases and post-reversal results by time from initial
endoscopic thoracic sympathetic clipping to reversal (visual analogue
scale score)
Time to reversal (mo) 6 mo >6 mo
n 12 22
Change in CS 4.5  3.4 3.1  3.4 NS
Control of HH 3.8  3.6 5.4  4.1 NS
Satisfaction 4.7  3.7 3.3  3.4 NS
CS, Compensatory sweating; HH, hyperhidrosis; NS, not significant.1374 The Journal of Thoracic and Cardiovascular SuSecond, sympathectomy including the T2 level is associ-
ated with a success rate of approximately 90% to 100% in
the treatment of craniofacial HH and facial blushing. How-
ever, it has been repeatedly reported that sympathectomy
including the T2 level is associated with significantly worse
CS and a lower degree of satisfaction postopera-
tively5,8,16,17,18 when compared with sympathectomy not in-
cluding T2. Similarly in our series, ETS-T2 and ETS-T2þ3
were both associated with a higher rate of severe CS and sig-
nificantly lower postoperative satisfaction when compared
with ETS-T3þ4. There was also a trend toward more reversal
procedures in the combined T2 and T2þ3 groups when com-
pared with the T3þ4 group.
CS is the most significant adverse effect after sympathec-
tomy. Approximately 10% of our patients sustained severe
CS, more than the 6% reported by Reisfeld and colleagues12
in their large cohort (1312) of patients, but less than reported
by other groups, who described up to 30% of patients with
severe CS symptoms.7,9,18 The common hypothesis for CS
is that this phenomenon is a thermoregulatory mechanism
by which the sweat glands attempt to compensate for the de-
creased amount of secretory tissue. Several authors have
therefore suggested that reducing the extent of sympathetic
nerve interruption will result in reducing the occurrence of
CS.17 Currently, however, there are no electrophysiologic
studies to support these concepts. In addition, it has been
suggested that the anatomic variations in the sympathetic
trunk, including aberrant pathways between the upper tho-
racic and the intercostal nerves, enable fibers to bypass the
sympathetic chain and might be one of the main reasons
for failure of surgical sympathectomy.23 As a result, some
surgeons are routinely dividing or coagulating all the aber-
rant fibers around the level of the sympathectomized chain.
Yet, there are no studies to support this hypothesis, and no
clinical data are available to support the routine use of this
maneuver during ETS. In our experience, only 3.4% of
the patients required redo surgery because of failure of the
original procedure, and most of them simply required the
addition of T3T4 clipping to a preexisting T2.
The main limitation in evaluating the results of surgical
sympathectomy is the inability to objectively measure the
outcome. Although most patients are satisfied with the
results, all the methods for outcome measurement are of
a subjective nature. Many centers have developed different
scales/parameters to evaluate success rate after sympathec-
tomy ETS, none of which is widely used by others. Only
a few groups are routinely monitoring physiologic parame-
ters, such as heart rate and skin temperature, during or after
the surgical procedure.25 However, these parameters might
not be precise or long-lasting.
Yet, in a procedure focused primarily on achieving high
patient satisfaction, the main outcome is, indeed, the pa-
tient’s subjective evaluation of his or her symptoms. Thus,
it seemed reasonable to assess our patients using the VAS,rgery c June 2009
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accurate self-assessment by patients.
The concept of potential reversibility of adverse effects af-
ter CS by clip removal is attractive and intuitively sound.
After sympathectomy using nerve cutting or various other
methods of nerve injury, the only reliable way to restore
trunk continuity is by using a nerve graft to interpose be-
tween the cut/injured ends.24 This is a complex surgery
that requires harvesting and anastomosis of nerves. How-
ever, if restoration of continuity in the sympathetic chain
by removal of clips that initially crushed the chain will allow
for renewal of conductivity in the trunk, then the method of
sympathetic clipping (in which the continuity of the sympa-
thetic trunk is maintained) is clearly preferable as the initial
surgical treatment for HH, because it maintains the option of
effective and relatively simple reversibility. Before the cur-
rent study, there were only a few reports assessing reversal
of sympathetic clipping,5,12-14,16 most of which are case re-
ports or small case series. Our group of 34 patients with re-
versal is the largest reported series to date. We are also the
only group to follow their reversal patients prospectively
for a relatively long period of time (up to 5 years). Although
we realize that the T3T4 reversal group was followed for
relatively short period (median of 5.1 months), simply re-
flecting the fact that we started performing T3T4 almost
exclusively during the last 3 years, the follow-up for the
other reversal groups was significantly longer. Thus, the
substantial decrease in CS in approximately half of the pa-
tients after reversal is reliable, and the results were main-
tained in some patients for several years. We do not have
a good explanation for the fact that approximately 40% of
patients did not experience recurrence of their original
sweating/blushing pattern after the reversal, especially be-
cause some did show reversal of their CS. It is unclear
why a patient may experience reduction of CS after reversal
while not experiencing recurrence of his/her original symp-
toms. Currently, there is no valid or reproductive animal
model to clarify the actual mechanism of HH and to validate
the concept of sympathectomy and reversal. The only re-
ported in vivo animal model to evaluate the activity of the
sympathetic chain within this concept was reported by
Lavian and colleagues,26 who developed an electrode device
that was implanted on the stellate ganglia of dogs to allow
for a chronic animal model with continuous recording of
neuroelectrical signals. They demonstrated long-term repro-
ductive signal recording by the device but have not repeated
it in the setup of a sympathectomy model. Thus, more re-
search is clearly needed to support the concept of sympa-
thectomy, and in particular that of reversibility.
CONCLUSIONS
What are the clinical implications of our study? First, the
study provides additional evidence to support previous re-
ports showing an excellent safety profile and long-term out-The Journal of Thoracic and Ccome for sympathectomy. Second, the study provides some
evidence for the usefulness of reversibility. It seems that re-
versal might help a substantial proportion of patients with
severe adverse effects after sympathectomy, and that the re-
sults of the reversal procedure are long-lasting. Third, the
fact that approximately half of the patients undergoing rever-
sal in our experience reported a substantial decrease in their
CS, but that approximately one third did not experience a re-
currence of their original HH even after clip removal, cannot
be simply explained by nerve regeneration after clip re-
moval. Thus, some exciting questions are raised with regard
to possible alternative mechanisms and the need for better
understanding of the activity of the sympathetic chain, as
well as its relationship to HH.
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Discussion
Dr James Allan (Boston, Mass). Thanks very much. That was
very nicely presented and I want to congratulate you on adding
a large body of data to the literature.
I find the data provocative in several respects. First, in your se-
ries, 25 patients (3.4%) underwent repeat surgery due to a lack of
effectiveness of the initial operation. The majority of these patients
had initially been clipped at just the T2 level for palmar hyperhidro-
sis. In my personal experience of about 60 patients, I have never
needed to reoperate on a patient; however, I perform a T2 to T4 ab-
lation with division of accessory nerves, not just a T2 clipping. So I
would like to know whether the initial failure in these patients re-
flects (1) that clipping at a given level may be inferior in efficacy
to cutting or ablating at the same level, (2) that some patients simply
require longer sympathectomies than others in an unpredictable
fashion, or (3) that the initial failures are a reflection of performing
a procedure that does not address accessory sympathetic fibers?
Dr Sugimura. Dr Allan, thank you very much for your com-
ments and questions.
It is true that we had 25 redo surgeries that required redo because
of suboptimal results or what looked like early recurrence of their
symptoms, and the majority were in patients that received T2 clip-
ping for palmar hyperhidrosis.
In regards to the difference between the clipping method and the
cutting or ablation method, I think that our results using the clipping
method are comparative to the results utilizing other methods in
terms of satisfaction or treatment success. Some authors with expe-
rience with both methods even suggest that clipping was more
effective. I do not think that the redos were a result of inferiority
of the clipping method. I personally think that accessory sympa-
thetic conduction might have been responsible, or at least in part,
for suboptimal results or early recurrences resulting in redo. We
do not routinely clip aberrant nerve fibers, and the fact that you
see more aberrant fibers at the T1/T2 levels, as compared to the
T3/T4 levels is the reason for my suspicion. Therefore when we
perform redo sympathetic clipping, if we find an aberrant fiber at
that time, we ablate that nerve. After experience with clipping at
both T2 and T3/T4 levels, we now strongly believe that T3/T4 clip-
ping is a far more superior method to T2 clipping that does not re-
quire further intervention to the accessory nerves. Because most of
the redos were done following T2 clipping, in fact we have added
clips to the T3/T4 levels in most of the cases at the time of redo.1376 The Journal of Thoracic and Cardiovascular SDr Allan. My second question for you relates to the 2 patients
(among the 34 patients who underwent reversal) that did so for rea-
sons other than compensatory hyperhidrosis. I believe from your
manuscript, one of them may have had a Horner’s syndrome and
the other may have had sexual dysfunction, which is a complication
that I was not aware of. Can you describe these 2 patients, if I’ve
understood the presentation correctly, and what their outcome
was after reversal?
Dr. Sugimura. The patient who presented with Horner’s-like
symptoms was a T2 clipping case done in the early era. It wasn’t
the typical presentation of symptoms, but there was a mild degree
of ptosis and some bloodshot conjunctiva, which was among mul-
tiple complaints including significant compensatory sweating. We
did perform reversal in that case.
Dr Allan. Was there symptomatic improvement in that patient
after reversal?
Dr Sugimura. There was mild symptomatic relief in that pa-
tient. The patient presenting with sexual dysfunction also had an
L2 to 4 chemical block of the sympathetic chain for plantar hyper-
hidrosis close to the time of thoracic sympathetic clipping.
Dr Allan. Finally, among the 32 patients who underwent rever-
sal for compensatory hyperhidrosis, did you notice a correlation be-
tween the resolution of the compensatory hyperhidrosis and the
subsequent recurrence of the primary symptom?
Dr Sugimura. As we showed in the presentation, there was
a trend toward association between the two changes in the symp-
toms, meaning if you do an early reversal, you’ll have more patients
reporting significant relief from their compensatory sweating and at
the same time less patients who can maintain their level of control
of hyperhidrosis.
Dr Allan. Thank you
DrDanMeyer (Dallas, Tex). That was an excellent presentation.
I have three quick questions. Do you do any intraoperative mon-
itoring, such as palmar temperature monitoring, to make sure that
you have interrupted the blood supply during your sympathec-
tomy?
Dr Sugimura. No, we do not.
Dr Meyer. Are there a group of patients that you’ve found that
you’ve predicted preoperative factors that may predict severe com-
pensatory sweating that you would not offer a sympathectomy to?
Because there are patients who have diffuse sweating, worse in the
hands or axillae, that you worry that they may get severe compen-
satory sweating postoperatively.
Dr Sugimura. I think it’s more about the indication for clipping. If
you are to treat a patient with a primary complaint of craniofacial hy-
perhidrosis, then we believe that it’s more effective to perform a T2
clipping. However, we know that T2 clipping is associated with
worse compensatory sweating. So if you call that a high-risk group
for significant compensatory sweating, then that might be the case.
Dr Meyer. And the last question, have you considered just do-
ing a T3 sympathectomy instead of the T3/T4 clipping? What do
you think the gain of the addition of the T4 is?
Dr Sugimura. First of all, we don’t have experience with single-
level clipping. We are aware of reports showing excellent results
and literally zero compensatory sweating with the single level sym-
pathectomy at the lower level of the sympathetic trunk, and I agree
that that is a method that we should look into in the future. I believe
that a lot of people who are experienced in this surgery think thaturgery c June 2009
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verse effects you create, and if you can achieve the same results
with less manipulation, I think that is the optimal way to treat.
Dr Douglas Wood (Seattle, Wash). I want to follow up on Dr
Allan’s last question, which I guess I’m not sure we answered ad-
equately. I think that he is asking whether in individual patients was
there a correlation in time of when the sympathectomy was re-
versed and the recurrence of hyperhidrosis and relief of compensa-
tory sweating? In individual patients was the relief of compensatory
sweating accompanied by a recurrence of symptoms?
Dr Sugimura. It usually was. But there was a small number of
patients who experienced relief from their compensatory sweating
after reversal while enjoying persistent control of hyperhidrosis,
and those patients were more in the T2 group—well, we had
more reversals in the T2 group to start with. My personal feeling
is that with all the measures that we use to look at the outcomes be-
ing so subjective, we have to be very careful in our attempt to quan-
tify the relationship between these 2 outcomes. In some people with
a huge burden of compensatory sweating, with even mild relief af-
ter reversal they might feel quite satisfied, regardless of the changein their state of hyperhidrosis. It’s hard to really understand the
quantitative association unless we do some confirmation with elec-
trophysiological studies.
Dr Allan. I agree that patient selection is a key component to
subsequent patient satisfaction. I would not want to bring 10% of
my patients back to the operating room due to a failure to control
the primary condition, or due to my creating a side effect that turns
out to be worse than the primary condition. Therefore, I make
a strong effort to be certain that the patient is significantly bothered
by palmar hyperhidrosis. I do not typically offer surgery for isolated
craniofacial hyperhidrosis, and also try to limit operating on iso-
lated axillary symptoms, as the reported efficacy of sympathectomy
for axillary symptoms is only about 70%.
Dr Sugimura. Thank you very much. I couldn’t agree more
with that comment. We are being more and more selective in our
patient selection. There are about 10% of patients who come to
see us with complaints of solely craniofacial hyperhidrosis or axil-
lary hyperhidrosis. Because we now know that sympathetic surgery
in this population is more likely to fail or cause significant adverse
effects, we basically discourage these patients from surgery.Appendix 1. Endoscopic thoracic sympathetic clipping follow-up questionnaire
1. How would you rate your current degree of facial / hand / armpit / foot 
sweating, or facial blushing?
None
Debilitating
2. How would you rate your current degree of compensatory / reflex sweating?
None
Debilitating
0 1 2 3 4 5 6 7 8 9 10
0 1 2 3 4 5 6 7 8 9 10
0 1 2 3 4 5 6 7 8 9 10
3. What is your current degree of satisfaction with the surgery (ETS)?
Not satisfied at all
1. Location of compensatory sweating: Face
(Mark all that apply) Chest
Abdomen 
Feet
Neck
Back
Buttocks/thighs
Gustatory
None
2.  Other adverse effects after sympathetic clipping:
_______________________________________________________________________
_______________________________________________________________________
Completely satisfied
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1. How would you rate your current degree of facial / hand / armpit / foot 
sweating, or facial blushing? 
Same as before ETS Complete dryness
2. How would you rate your current degree of compensatory / reflex sweating? 
Same as before reversal Back to normal (before ETS)
3. What is your current degree of satisfaction after reversal? 
Not satisfied at all 
Other effects following removal of sympathetic clips:
0 1 2 3 4 5 6 7 8 9 10
0 1 2 3 4 5 6 7 8 9 10
0 1 2 3 4 5 6 7 8 9 10
Completely satisfied
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